Call for SADC HIV regional committee

3 December 2007

Southern Africa Development Community (SADC) Parliamentary Forum officials, meeting on November 24 in the southern Angola city Ondjiva, Cunene Province, have recommended the creation of a regional committee to tackle HIV/AIDS in that country and Namibia.

This was manifested in a ceremony that served to balance the five-day work carried out in Cunene and in the neighboring Namibia, by the SADC parliamentarians, aimed at checking the epidemiological situation, in terms of HIV/AIDS, in the two countries, reports the Angola Press Agency.

Speaking to the local press, the head of the SADC parliamentary team, Helder de Albuquerque, stressed that such a measure will bring about better results in the fight against HIV/Aids, mainly at the Angola/Namibia border regions. Namibian parliamentarian Moses Amweelo praised the idea of creating a regional committee, adding that, in so doing, this will strengthen the joint activities in the fight against the diseases that are more frequently recorded at the common border.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight